D-0047-2024 Class I Terminated
FDA drug recall D-0047-2024 was initiated by VistaPharm LLC on Oct 18, 2023 and is designated Class I. Reason for recall: Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus. The recall status is terminated (terminated Apr 30, 2024). Affected quantity: 180 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 25, 2023
- Initiation Date
- Oct 18, 2023
- Termination Date
- Apr 30, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 180 bottles
Product Description
Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16
Reason for Recall
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
Distribution Pattern
USA Nationwide
Code Information
Lot#: 810300, Exp 10/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0047-2024
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026